Letter to the Editor
Copyright ©The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Gastroenterol. Feb 28, 2024; 30(8): 991-993
Published online Feb 28, 2024. doi: 10.3748/wjg.v30.i8.991
Monitoring of hepatocellular carcinoma
Imen Akkari, Hanen Jaziri
Imen Akkari, Department of Gastroenterology, University Hospital of Hached, University of Sousse, Faculty of Medicine of Sousse, Sousse 4000, Tunisia
Hanen Jaziri, Department of Gastroenterology, University Hospital of Sahloul, University of Sousse, Faculty of Medicine of Sousse, Sousse 4054, Tunisia
Author contributions: Akkari I designed the report; Jaziri H read and agreed to the final manuscript.
Conflict-of-interest statement: All the authors report no relevant conflicts of interest for this article.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Imen Akkari, MD, Associate Professor, Department of Gastroenterology, University Hospital of Hached, University of Sousse, Faculty of Medicine of Sousse, Rue Mohamed Karoui, Sousse 4000, Tunisia. imenakkaribm@gmail.com
Received: October 3, 2023
Peer-review started: October 3, 2023
First decision: December 6, 2023
Revised: December 12, 2023
Accepted: February 1, 2024
Article in press: February 1, 2024
Published online: February 28, 2024
Abstract

Screening for hepatocellular carcinoma in patients at risk is an evidence-based approach; however, adherence to the monitoring protocol recommended by international guidelines is difficult. Hence, there is a need to use the best scr-eening options and refine the selection of patients at risk in the future.

Keywords: Hepatocellular carcinoma, Cirrhosis, Risk factors, Surveillance, Imaging, Diagnosis

Core Tip: Hepatocellular carcinoma is a public health problem, and the majority of cases occur in patients with cirrhosis. The screening method for this disease has been the subject of several studies. This Editorial discusses the study titled “Hepatocellular carcinoma surveillance: An evidence-based approach” that was published in World Journal of Gastroenterology in 2019.